NUCALA
As listed in the register: NUCALA
100 mg · solution
- Prescription only
- Breathing, airways, allergies and cough
- Active substance
- Mepolizumab
- Made by
- Glaxosmithkline Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Nucala). It describes the substance, not this exact product.
Mepolizumab is an IL-5 antagonist (IgG1 kappa).
IL-5 is the major cytokine responsible for the growth and differentiation, recruitment, activation, and survival of eosinophils.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-08-06
Safety of the active substance
From the US prescribing label for the same active substance (Nucala). It describes the substance, not this exact product.
- NUCALA is contraindicated in patients with a history of hypersensitivity to mepolizumab or excipients in the formulation [see Warnings and Precautions ( 5.1 ), Description ( 11 )].
- History of hypersensitivity to mepolizumab or excipients in the formulation.
Most common adverse reactions (incidence ≥5%):.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Glaxosmithkline Inc |
|---|---|
| Active substance | Mepolizumab |
| Used in | Breathing, airways, allergies and cough |
| Strength | 100 mg |
| Form | solution |
| Classification | R03DX09 · Breathing, airways, allergies and cough |
| Route | subcutaneous |
| Dispensing (as stated by the register) | SCHEDULE D · PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02492997 |
| DPD drug code | 98297 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
3 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- solution3 products
- 40 mg
100 mg2
100 mg · 2 companies
- Glaxosmithkline Inc · this page
- Glaxosmithkline Inc
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.